Investors

Targeting Immune Checkpoints Using Self-Delivering RNAi (sd-rxRNA®) Technology

Jan 23, 2018 at 11:50 AM EST

Presenter:  James Cardia, Ph.D., Director of Business Development and Intellectual Property

Supporting Materials

Investors